Lionco(SH:603669) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-06-19 00:45Core Viewpoint - The company, Lingkang Pharmaceutical Group Co., Ltd., is set to hold an online performance briefing to discuss its 2024 annual report and 2025 Q1 report, addressing investor concerns and questions [2][3]. Group 1: Meeting Details - The performance briefing is scheduled for June 26, 2025, from 15:00 to 16:00 [4]. - The meeting will take place at the Shanghai Securities News and China Securities Network Roadshow Center, accessible via an online platform [4]. - The format of the meeting will be an interactive text-based online session [3][4]. Group 2: Participation Information - Investors can submit their questions and concerns to the company via fax, phone, or email by June 25, 2025, at 17:30 [5]. - Investors can participate in the briefing on June 26, 2025, by logging into the online platform [5]. Group 3: Contact Information - The company has provided contact persons for inquiries: Sui Guoping and Liao Baoyu, with a contact number and fax number both listed as 0571-81103508 [6]. - An email address for investor relations is also provided: ir@lingkang.com.cn [6]. Group 4: Post-Meeting Access - After the briefing, investors can access the meeting's main content and details through the Shanghai Securities News and China Securities Network Roadshow Center [7].